Keyword search (4,163 papers available)

"drugs" Keyword-tagged Publications:

Title Authors PubMed ID
1 Scapegoated communities, shared struggles: A call for solidarity with people who use drugs and queer and trans people London-Nadeau K; Barborini C; Haines-Saah R; Bazarov M; Bristowe S; Khorkhordina M; Lemay-Gaulin M; Gorka C; Juster RP; D' Alessio H; Chadi N; 40633507
PSYCHOLOGY
2 Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies Lu H; Hong T; Jiang Y; Whiteway M; Zhang S; 37307922
BIOLOGY
3 Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence Mahri M; Shen N; Berrizbeitia F; Rodan R; Daer A; Faigan M; Taqi D; Wu KY; Ahmadi M; Ducret M; Emami E; Tamimi F; 33181361
CONCORDIA
4 Chronic Neuroleptic-Induced Parkinsonism Examined with Positron Emission Tomography. Galoppin M, Berroir P, Soucy JP, Suzuki Y, Lavigne GJ, Gagnon JF, Montplaisir JY, Stip E, Blanchet PJ 32353194
PERFORM
5 Hydrated electrons induce the formation of interstrand cross-links in DNA modified by cisplatin adducts Behmand B; Noronha AM; Wilds CJ; Marignier JL; Mostafavi M; Wagner JR; Hunting DJ; Sanche L; 32211848
CHEMBIOCHEM
6 Adolescent media use and its association to wellbeing in a Canadian national sample. Fitzpatrick C, Burkhalter R, Asbridge M 31024788
PERFORM

 

Title:Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies
Authors:Lu HHong TJiang YWhiteway MZhang S
Link:https://pubmed.ncbi.nlm.nih.gov/37307922/
DOI:10.1016/j.addr.2023.114960
Publication:Advanced drug delivery reviews
Keywords:Antifungal drugsAntifungal immunotherapyAntifungal targetsCandidiasisCutaneous infectionSystemic infection
PMID:37307922 Category: Date Added:2023-06-13
Dept Affiliation: BIOLOGY

Description:

Candidiasis is an infection caused by fungi from a Candida species, most commonly Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on human skin and mucous membranes of the mouth, intestines or vagina. It can cause a wide variety of mucocutaneous barrier and systemic infections; and becomes a severe health problem in HIV/AIDS patients and in individuals who are immunocompromised following chemotherapy, treatment with immunosuppressive agents or after antibiotic-induced dysbiosis. However, the immune mechanism of host resistance to C. albicans infection is not fully understood, there are a limited number of therapeutic antifungal drugs for candidiasis, and these have disadvantages that limit their clinical application. Therefore, it is urgent to uncover the immune mechanisms of the host protecting against candidiasis and to develop new antifungal strategies. This review synthesizes current knowledge of host immune defense mechanisms from cutaneous candidiasis to invasive C. albicans infection and documents promising insights for treating candidiasis through inhibitors of potential antifungal target proteins.





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University